Proffitt & Goodson’s iShares US Medical Devices ETF IHI Stock Holding History

Proffitt & Goodson’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.46K	Buy	+151	New	+$7.67K	﹤0.01%	258

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Proffitt & Goodson's IHI Position: Q2 2026 in Review

Proffitt & Goodson opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 151 shares worth $7.46K. The stake represents ﹤0.01% of the portfolio and ranks #258 among its holdings.

501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Proffitt & Goodson held 151 shares of iShares US Medical Devices ETF worth $7.46K as of Q2 2026.
iShares US Medical Devices ETF was a new Proffitt & Goodson position in Q2 2026.
iShares US Medical Devices ETF made up ﹤0.01% of Proffitt & Goodson's portfolio in Q2 2026, its #258 holding.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.